Inhibiting the expression of SHIP2 may be the new target to improve insulin resistance, treat type 2 diabetes and metabolic syndrome.

• 抑制内源性SHIP2蛋白表达,可能成为改善胰岛素抵抗及治疗2型糖尿病和代谢综合征的新靶点。